Literature DB >> 12444126

Inhibition of human CD4(+)CD25(+high) regulatory T cell function.

Clare Baecher-Allan1, Vissia Viglietta, David A Hafler.   

Abstract

CD4(+)CD25(+high) T cells are potent regulators of autoreactive T cells. However, it is unclear how regulatory CD4(+)CD25(+high) cells discriminate between desirable inflammatory immune responses to microbial Ags and potentially pathologic responses by autoreactive T cells. In this study, an in vitro model was created that allowed differential activation of regulatory CD4(+)CD25(+high) and responder CD4(+) T cells. If CD4(+)CD25(+high) regulatory cells were strongly activated, they maintained suppressive effector function for only 15 h, while stimulation with weaker TCR stimuli produced regulatory cells that were suppressive until 60 h after activation. In contrast, strongly activated CD4(+) responder T cells were resistant to regulation at all time points, while weakly stimulated CD4(+) cells were sensitive to suppression until 38 or 60 h after activation depending upon the strength of the stimulus. The extent of suppression mediated by CD4(+)CD25(+high) cells also depended on the strength of stimulation in an Ag-specific system. Thus, the stronger the TCR signal, the more rapidly and more completely the responder cells become refractory to suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444126     DOI: 10.4049/jimmunol.169.11.6210

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

2.  Costimulatory signals controlling regulatory T cells.

Authors:  Joerg Ermann; C Garrison Fathman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 3.  CD4+ CD25+ Treg: divide and rule?

Authors:  Lucy S K Walker
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

4.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

5.  In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

Authors:  Irini Sereti; Hiromi Imamichi; Ven Natarajan; Tomozumi Imamichi; Meena S Ramchandani; Yunden Badralmaa; Steve C Berg; Julia A Metcalf; Barbara K Hahn; Jean M Shen; April Powers; Richard T Davey; Joseph A Kovacs; Ethan M Shevach; H Clifford Lane
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

6.  IL-17-producing human peripheral regulatory T cells retain suppressive function.

Authors:  Gaëlle Beriou; Cristina M Costantino; Charles W Ashley; Li Yang; Vijay K Kuchroo; Clare Baecher-Allan; David A Hafler
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

7.  Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes.

Authors:  S Glisic-Milosavljevic; T Wang; M Koppen; J Kramer; S Ehlenbach; J Waukau; P Jailwala; S Jana; R Alemzadeh; S Ghosh
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

8.  Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.

Authors:  Iris Bellinghausen; Bettina König; Ingo Böttcher; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 9.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.

Authors:  Cécile Taflin; Makoto Miyara; Dominique Nochy; Dominique Valeyre; Jean-Marc Naccache; Frédéric Altare; Pascale Salek-Peyron; Cécile Badoual; Patrick Bruneval; Julien Haroche; Alexis Mathian; Zahir Amoura; Gary Hill; Guy Gorochov
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.